| Literature DB >> 2273299 |
D D Von Hoff1, B Metch, J G Lucas, S P Balcerzak, S M Grunberg, S E Rivkin.
Abstract
Fourteen evaluable patients with diffuse malignant mesothelioma were treated with a once-a-day for 5 days out of 7 for 6 weeks regimen of recombinant interferon-beta (IFN-beta ser). No responses were noted. The major toxicities included fever, chills, nausea, vomiting, and anorexia. IFN-beta ser at this dose and schedule does not appear to be an active single agent for patients with refractory malignant mesothelioma.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2273299 DOI： 10.1089/jir.1990.10.531
Source DB: PubMed Journal: J Interferon Res ISSN： 0197-8357